Showing results (191-200 of 227) with videos related to

Sort By:
Pageof 23
Molecular Cell|December 5, 2024
p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosisQuan Liao, Jun Deng, Jing Tong, et al.
Advances in Therapy|September 14, 2024
Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c StudyJianping Xiong, Weiwei Ouyang, Mengxiang Yang, et al.
Cancer Immunology, Immunotherapy : CII|February 15, 2022
Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancersYulong Zheng, Anna Rachelle Austria Mislang, Jermaine Coward, et al.
Journal for Immunotherapy of Cancer|December 22, 2021
Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)Yunpeng Yang, Ting Zhou, Xiaozhong Chen, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|December 22, 2021
Validation of Soft Labels in Developing Deep Learning Algorithms for Detecting Lesions of Myopic Maculopathy From Optical Coherence Tomographic ImagesRan Du, Shiqi Xie, Yuxin Fang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2018
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients WithShukui Qin, Jin Li, Liwei Wang, et al.
Pageof 23